News

Daiichi Sankyo brought patent infringement actions in Tokyo District Court against seven generics companies: Shiono Chemical Co, Taiyo Yakuhin Co, Takata Seiyaku Co, Nichi-Iko Pharmaceutical Co, Nihon Generic

In the US several patients with cancer have now been treated with the company’s survivin inhibitor, which is jointly developed by Santaris Pharma and Enzon Pharmaceuticals. The FDA

ImVisioN Therapeutics, a biopharmaceutical company, has obtained positive Phase I clinical results for its lead product, IVN201, an immunotherapeutic product for the treatment of cat dander allergy. The

Mr McKee is the executive vice president and CFO of Barr Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries. Prior to joining Barr, Mr McKee served as director of

The company has signed a lease for a 40,405 square foot building in Austin, Texas, that was previously used by Sorin Carbomedics. On-X Life will begin a 19-month

The approval of Lexapro for the treatment of adolescent depression was supported by two placebo-controlled studies, one conducted in adolescent patients taking Lexapro and one conducted in children

Navigenics, a genomics testing company, has acquired the Affymetrix clinical services laboratory, a CLIA-certified testing facility that provides molecular genome scanning using the Affymetrix GeneChip microarray platform. With

Roche has reported positive results from ToGA, an international Phase III trial investigating the benefit of Herceptin as the first therapy for patients with advanced and inoperable stomach

Gardner graduated from Concordia University and is a Certified General Accountant. “As we head into an accelerated period of growth with the launch of EclecticaTM and the growing